Eli Lilly and Novo Nordisk raise profit outlook as weight-loss drug demand soars

6 hours ago

Drugmakers’ share prices diverge as investors take dim view of Novo’s over-reliance on obesity treatments
Click here to Read More
Previous Article
Flutter chief steps down as gambling group cuts guidance
Next Article
Strong box office for ‘Toy Story 5’ boosts Disney as US theme parks rebound

Related Finance Updates:

Are you sure? You want to delete this comment..! Remove Cancel

Comments (0)

    Leave a comment